| NCT ID | NCT05779462 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Lille |
| Condition | Endometriosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 52 participants |
| Start Date | 2023-05-23 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 52 participants in total. It began in 2023-05-23 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Endometriosis is a frequent pathology with an estimated prevalence of 10% of women of childbearing age. There is no exact correspondence between the symptoms described by the patients and the severity of the lesions, which makes clinical diagnosis difficult. It therefore seems important to improve the complementary examinations available to make the diagnosis more precise and to better study the effectiveness of the treatments implemented. The clinical examination and per-surgical findings of patients with deep pelvic endometriosis show a clear decrease in the mobility of the pelvic organs in relation to each other, but few studies have looked at this mobility, which could however have an implication in explaining the pathophysiology of the disease and the symptomatology of the patients, as well as in the detection of lesions preoperatively. The persistence of hypo-mobility could also help to understand treatment failures.
Eligibility Criteria
Inclusion Criteria: * Patient referred for suspected pelvic endometriosis requiring pelvic MRI * Female, nulliparous, * patient with signed written consent, patient with health insurance, * patient willing to comply with all study procedures and duration Exclusion Criteria: * BMI \> 35, * history of hereditary collagen and elastic tissue disease, * history of pelviperitonitis, * history of major pelvic surgery, * inability to receive informed information, * inability to participate in the entire study, * lack of social security coverage, * refusal to sign consent
Contact & Investigator
Chrystele RUBOD, MD,PhD
PRINCIPAL INVESTIGATOR
University Hospital, Lille
Frequently Asked Questions
Who can join the NCT05779462 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05779462 currently recruiting?
Yes, NCT05779462 is actively recruiting participants. Contact the research team at chrystele.rubod@chru-lille.fr for enrollment information.
Where is the NCT05779462 trial being conducted?
This trial is being conducted at Lille, France.
Who is sponsoring the NCT05779462 clinical trial?
NCT05779462 is sponsored by University Hospital, Lille. The principal investigator is Chrystele RUBOD, MD,PhD at University Hospital, Lille. The trial plans to enroll 52 participants.